Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding.
暂无分享,去创建一个
J Zeleznikow | V Brusic | N Petrovsky | N. Petrovsky | C. Schönbach | V. Brusic | John Zeleznikow | J. Kazura | K Bucci | C Schönbach | J W Kazura | K. Bucci
[1] V. Apostolopoulos,et al. MUC1 peptide epitopes associated with five different H‐2 class I molecules , 1997, European journal of immunology.
[2] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 1997, Nucleic Acids Res..
[3] S. Clementi,et al. The importance of secondary anchor residue motifs of HLA class I proteins: a chemometric approach. , 1994, Molecular immunology.
[4] P. Travers,et al. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. , 1998, Journal of immunology.
[5] R. J. Stonier,et al. Complex Systems: Mechanism of Adaptation , 1994 .
[6] F. Marincola,et al. Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. , 1999, Journal of immunology.
[7] L C Harrison,et al. MHCPEP: a database of MHC-binding peptides. , 1994, Nucleic acids research.
[8] Mark Lindsey,et al. Complexity among constituents of the HLA-B*1501 peptide motif , 1998, Immunogenetics.
[9] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[10] E. Huarte,et al. Specific and general HLA-DR binding motifs: comparison of algorithms. , 2000, Human immunology.
[11] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[12] R Elber,et al. Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. , 1998, Folding & design.
[13] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[14] L. Szekely,et al. Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay , 1994, European journal of immunology.
[15] P. Cresswell,et al. Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.
[16] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[17] V. Brusic,et al. Neural network-based prediction of candidate T-cell epitopes , 1998, Nature Biotechnology.
[18] Vladimir Brusic,et al. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network , 1998, Bioinform..
[19] Vladimir Brusic,et al. MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..
[20] M. Vaillant,et al. Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. , 1999, The American journal of tropical medicine and hygiene.
[21] R. Henderson,et al. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. , 1995, Journal of immunology.
[22] S Walters,et al. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic , 1997, Infection and immunity.
[23] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[24] P. Miller. Medical informatics in clinical medicine and the biosciences , 1995, Nature Medicine.
[25] S. Hoffman,et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. , 1998, Science.
[26] S. H. van der Burg,et al. Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes , 1993, European journal of immunology.
[27] Cvi Scotland,et al. Newsletter Issue 1 , 1970 .
[28] T. Elliott,et al. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. , 1993, Journal of immunological methods.
[29] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[30] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[31] H Mamitsuka,et al. Predicting peptides that bind to MHC molecules using supervised learning of hidden markov models , 1998, Proteins.
[32] S. H. van der Burg,et al. Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen , 1996, European journal of immunology.
[33] R. R. Mallios,et al. Class II MHC quantitative binding motifs derived from a large molecular database with a versatile iterative stepwise discriminant analysis meta- algorithm , 1999, Bioinform..